Cargando…

Regulatory Networks of LncRNA MALAT-1 in Cancer

Long noncoding (lnc)RNAs are a group of RNAs with a length greater than 200 nt that do not encode a protein but play an essential role in regulating the expression of target genes in normal biological contexts as well as pathologic processes including tumorigenesis. The lncRNA metastasis-associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Shijian, Wang, Yanhong, Li, Hang, Chen, Leilei, Liu, Quanzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575067/
https://www.ncbi.nlm.nih.gov/pubmed/33116873
http://dx.doi.org/10.2147/CMAR.S276022
_version_ 1783597742256291840
author Fu, Shijian
Wang, Yanhong
Li, Hang
Chen, Leilei
Liu, Quanzhong
author_facet Fu, Shijian
Wang, Yanhong
Li, Hang
Chen, Leilei
Liu, Quanzhong
author_sort Fu, Shijian
collection PubMed
description Long noncoding (lnc)RNAs are a group of RNAs with a length greater than 200 nt that do not encode a protein but play an essential role in regulating the expression of target genes in normal biological contexts as well as pathologic processes including tumorigenesis. The lncRNA metastasis-associated lung adenocarcinoma transcript (MALAT)-1 has been widely studied in cancer. In this review, we describe the known functions of MALAT-1; its mechanisms of action; and associated signaling pathways and their clinical significance in different cancers. In most malignancies, including lung, colorectal, thyroid, and other cancers, MALAT-1 functions as an oncogene and is upregulated in tumors and tumor cell lines. MALAT-1 has a distinct mechanism of action in each cancer type and is thus at the center of large gene regulatory networks. Dysregulation of MALAT-1 affects cellular processes such as alternative splicing, epithelial–mesenchymal transition, apoptosis, and autophagy, which ultimately results in the abnormal cell proliferation, invasion, and migration that characterize cancers. In other malignancies, such as glioma and endometrial carcinoma, MALAT-1 functions as a tumor suppressor and thus forms additional regulatory networks. The current evidence indicates that MALAT-1 and its associated signaling pathways can serve as diagnostic or prognostic biomarker or therapeutic target in the treatment of many cancers.
format Online
Article
Text
id pubmed-7575067
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-75750672020-10-27 Regulatory Networks of LncRNA MALAT-1 in Cancer Fu, Shijian Wang, Yanhong Li, Hang Chen, Leilei Liu, Quanzhong Cancer Manag Res Review Long noncoding (lnc)RNAs are a group of RNAs with a length greater than 200 nt that do not encode a protein but play an essential role in regulating the expression of target genes in normal biological contexts as well as pathologic processes including tumorigenesis. The lncRNA metastasis-associated lung adenocarcinoma transcript (MALAT)-1 has been widely studied in cancer. In this review, we describe the known functions of MALAT-1; its mechanisms of action; and associated signaling pathways and their clinical significance in different cancers. In most malignancies, including lung, colorectal, thyroid, and other cancers, MALAT-1 functions as an oncogene and is upregulated in tumors and tumor cell lines. MALAT-1 has a distinct mechanism of action in each cancer type and is thus at the center of large gene regulatory networks. Dysregulation of MALAT-1 affects cellular processes such as alternative splicing, epithelial–mesenchymal transition, apoptosis, and autophagy, which ultimately results in the abnormal cell proliferation, invasion, and migration that characterize cancers. In other malignancies, such as glioma and endometrial carcinoma, MALAT-1 functions as a tumor suppressor and thus forms additional regulatory networks. The current evidence indicates that MALAT-1 and its associated signaling pathways can serve as diagnostic or prognostic biomarker or therapeutic target in the treatment of many cancers. Dove 2020-10-15 /pmc/articles/PMC7575067/ /pubmed/33116873 http://dx.doi.org/10.2147/CMAR.S276022 Text en © 2020 Fu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Fu, Shijian
Wang, Yanhong
Li, Hang
Chen, Leilei
Liu, Quanzhong
Regulatory Networks of LncRNA MALAT-1 in Cancer
title Regulatory Networks of LncRNA MALAT-1 in Cancer
title_full Regulatory Networks of LncRNA MALAT-1 in Cancer
title_fullStr Regulatory Networks of LncRNA MALAT-1 in Cancer
title_full_unstemmed Regulatory Networks of LncRNA MALAT-1 in Cancer
title_short Regulatory Networks of LncRNA MALAT-1 in Cancer
title_sort regulatory networks of lncrna malat-1 in cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575067/
https://www.ncbi.nlm.nih.gov/pubmed/33116873
http://dx.doi.org/10.2147/CMAR.S276022
work_keys_str_mv AT fushijian regulatorynetworksoflncrnamalat1incancer
AT wangyanhong regulatorynetworksoflncrnamalat1incancer
AT lihang regulatorynetworksoflncrnamalat1incancer
AT chenleilei regulatorynetworksoflncrnamalat1incancer
AT liuquanzhong regulatorynetworksoflncrnamalat1incancer